DCGI Grants Market Approval To Covishield & Covaxin With Conditions

The Drugs Controller General of India (DCGI) on January 27, granted regular market approval to India's Covaxin and Covishield vaccines against COVID-19. Following SEC's recommendations, the DCGI allowed only hospitals and clinics to purchase the SII's Covishield and Bharat Biotech's Covaxin under the New Drugs And Clinical Trials 2019 Act. However, the authority needs to submit data every six months to the DCGI and update on CoWIN app.